Robert Seevers, Senior Advisor at Pearl Pathways, has been invited to deliver a lecture at Purdue University this Friday, February 16. Seevers will speak to an MS-level drug discovery class that aims to teach students how to apply and navigate current FDA regulations to deliver a drug, device, or diagnostic to market.

Seevers’  lecture topics will include:

• what constitutes an Investigational New Drug (IND) and a New Drug Application NDA
• a discussion of what the IND and NDA means to the U.S. Food and Drug Administration (FDA)
• the IND and NDA review processes
• the “right” and “wrong” ways to ask FDA questions
• the power of FDA guidances
• the importance of understanding the risk/benefit ratio of a particular drug for a specific indication

For more updates on Pearl Pathways news and events, follow our LinkedIn page.